Literature DB >> 7822295

Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.

X Y Han1, D R Galloway.   

Abstract

Pseudomonas aeruginosa exotoxin A (ETA) is a member of the family of bacterial ADP-ribosylating toxins which use NAD+ as the ADP-ribose donor. By analogy to diphtheria and pertussis toxins, the His440 residue of ETA has been proposed to be one of the critical residues within the active site of the toxin. In this study the role of the His440 residue was explored through site-directed mutagenesis which resulted in the production of ETA proteins containing Ala, Asn, and Phe substitutions at the 440 position. The His440-substituted ETA proteins were purified and analyzed. All substitutions at the 440 site displayed severely reduced ADP-ribosylation activity (> 1000-fold). However, NAD glycohydrolase activity remained intact and in the case of ETAH440N actually increased 10-fold. NAD+ binding is not affected by substitutions at the 440 site as indicated by similar Km values for the ETA variants tested. Conformational integrity of the mutant toxins appears to be largely unaffected as assessed by analysis with a conformation-sensitive monoclonal antibody as well as sensitivity to proteinase digestion. In view of the location of His440 residue within or close to the proposed NAD(+)-binding site, these results suggest that His440 may be a catalytic residue involved in the transfer of the ADP-ribose moiety to the EF-2 substrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7822295     DOI: 10.1074/jbc.270.2.679

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  8 in total

1.  Vibrio fischeri genes hvnA and hvnB encode secreted NAD(+)-glycohydrolases.

Authors:  E V Stabb; K A Reich; E G Ruby
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

Review 2.  Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Authors:  Robert J Kreitman
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

3.  Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.

Authors:  Susan P Yates; Patricia L Taylor; René Jørgensen; Dana Ferraris; Jie Zhang; Gregers R Andersen; A Rod Merrill
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.766

4.  Primary T cells for mRNA-mediated immunotoxin delivery.

Authors:  R Eggers; A Philippi; M O Altmeyer; F Breinig; M J Schmitt
Journal:  Gene Ther       Date:  2017-09-22       Impact factor: 4.184

5.  The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.

Authors:  M Li; F Dyda; I Benhar; I Pastan; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 12.779

6.  Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.

Authors:  M Li; F Dyda; I Benhar; I Pastan; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 12.779

7.  Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.

Authors:  Susan P Yates; Allan R Merrill
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.766

8.  Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis.

Authors:  Sirijan Santajit; Watee Seesuay; Kodchakorn Mahasongkram; Nitat Sookrung; Sumate Ampawong; Onrapak Reamtong; Pornphan Diraphat; Wanpen Chaicumpa; Nitaya Indrawattana
Journal:  Sci Rep       Date:  2019-10-17       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.